Fagotti, Anna
 Distribuzione geografica
Continente #
NA - Nord America 9.141
EU - Europa 8.408
AS - Asia 4.643
SA - Sud America 1.055
AF - Africa 109
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 13
Totale 23.395
Nazione #
US - Stati Uniti d'America 9.033
DE - Germania 1.885
SG - Singapore 1.723
SE - Svezia 1.715
IT - Italia 1.534
CN - Cina 1.493
BR - Brasile 965
IE - Irlanda 601
FR - Francia 557
UA - Ucraina 509
IN - India 506
PL - Polonia 382
ID - Indonesia 381
GB - Regno Unito 291
FI - Finlandia 260
RU - Federazione Russa 241
KR - Corea 93
TR - Turchia 93
HK - Hong Kong 90
NL - Olanda 76
BE - Belgio 71
AT - Austria 59
CA - Canada 59
CZ - Repubblica Ceca 50
CI - Costa d'Avorio 47
JP - Giappone 40
IR - Iran 35
VN - Vietnam 34
ES - Italia 28
AR - Argentina 25
MX - Messico 23
CH - Svizzera 22
RO - Romania 20
AU - Australia 19
PH - Filippine 16
ZA - Sudafrica 16
LT - Lituania 15
IQ - Iraq 14
MA - Marocco 14
BD - Bangladesh 13
CL - Cile 13
CO - Colombia 13
GR - Grecia 12
PE - Perù 12
PK - Pakistan 12
UZ - Uzbekistan 12
BZ - Belize 11
EG - Egitto 11
SA - Arabia Saudita 11
HR - Croazia 10
HU - Ungheria 10
IL - Israele 10
EC - Ecuador 9
EU - Europa 9
AE - Emirati Arabi Uniti 8
KE - Kenya 8
KZ - Kazakistan 8
LV - Lettonia 8
OM - Oman 8
PT - Portogallo 8
DK - Danimarca 7
NZ - Nuova Zelanda 7
PY - Paraguay 7
BG - Bulgaria 6
KG - Kirghizistan 6
NO - Norvegia 6
MD - Moldavia 5
MY - Malesia 5
AZ - Azerbaigian 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
LA - Repubblica Popolare Democratica del Laos 4
LK - Sri Lanka 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
AM - Armenia 3
EE - Estonia 3
HN - Honduras 3
JO - Giordania 3
NP - Nepal 3
PA - Panama 3
RS - Serbia 3
AL - Albania 2
AO - Angola 2
ET - Etiopia 2
GF - Guiana Francese 2
IS - Islanda 2
JM - Giamaica 2
LI - Liechtenstein 2
MK - Macedonia 2
NG - Nigeria 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
Totale 23.378
Città #
Chandler 2.063
Singapore 998
Ashburn 787
Dublin 595
San Mateo 402
Jakarta 368
Warsaw 348
Hyderabad 330
Rome 321
Jacksonville 294
Wilmington 287
Ann Arbor 259
New York 254
Boston 235
Milan 214
Nanjing 210
Princeton 185
Woodbridge 179
Moscow 175
Beijing 167
Houston 165
Fairfield 158
Marseille 157
Dearborn 147
Helsinki 127
Cattolica 126
Los Angeles 120
Seattle 111
Hefei 108
Nürnberg 105
Redwood City 99
Lawrence 97
Frankfurt am Main 94
Seoul 86
The Dalles 84
Boardman 83
São Paulo 78
Hong Kong 76
Munich 71
Nanchang 66
Brussels 65
Nuremberg 64
Bremen 56
Mountain View 54
Düsseldorf 53
Hangzhou 53
Izmir 50
Kunming 49
Abidjan 47
Norwalk 45
Cambridge 44
London 44
Zhengzhou 42
Leawood 41
Vienna 40
Fuzhou 36
Rio de Janeiro 36
Guangzhou 34
Hebei 34
San Francisco 34
Belo Horizonte 33
Shanghai 33
Augusta 32
Shenyang 32
Amsterdam 31
Changsha 31
Chicago 31
Redmond 30
Detroit 28
Oggiono 28
University Park 28
Busto Arsizio 27
Pune 27
Washington 26
Lancaster 25
Naples 25
Toronto 25
Bari 24
Brasília 24
Lauterbourg 24
Olomouc 24
Falkenstein 23
Santa Clara 22
Tianjin 22
Andover 21
Lappeenranta 21
Portsmouth 21
Jiaxing 20
Paris 20
Falls Church 19
Roubaix 19
North Bergen 17
Salvador 17
San Jose 17
Edinburgh 15
Fremont 15
Tokyo 15
Ardabil 14
Phoenix 14
Salò 14
Totale 12.684
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 811
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 323
Laparoendoscopic Single-Site Surgery (LESS) for Treatment of Benign Adnexal Disease: Single-Center Experience Over 3-Years 312
A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. 252
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 245
Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials. 241
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 175
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 175
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 174
Advanced vulvar carcinoma: is it worth operating? A perioperative management protocol for radical and reconstructive surgery 157
Delaying surgery for patients with a previous SARS-CoV-2 infection 157
Total laparoscopic hysterectomy in early-stage endometrial cancer using an intrauterine manipulator: is it a bias for frozen section analysis? Case-control study 156
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 155
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 147
Urologic surgery in gynecologic oncology: a large single-institution experience 146
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 145
Laparoscopic, minilaparoscopic and single-port hysterectomy: perioperative outcomes 143
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 142
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 139
The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. 136
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data 136
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 135
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 135
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 134
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 127
Sexual and reproductive outcomes in early stage cervical cancer patients after excisional cone as a fertility-sparing surgery: An italian experience 125
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 125
Importance of a specialized pathologist for the examination of frozen sections of adnexal masses. 117
Ultrasound evaluation of intra-abdominal sites of disease to predict the likelihood of suboptimal cytoreduction in advanced ovarian cancer: a propective study 116
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 115
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 115
Teaching and training in laparoscopic surgery: experience of Catholic Laparoscopy Advanced Surgery School in the basic gynecological surgery 114
Learning a new robotic surgical device: Telelap Alf X in gynaecological surgery 112
Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study 108
Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer 106
Risk of postoperative pelvic abscess in major gynecologic oncology surgery: one-year single-institution experience 106
Fusion imaging in the preoperative assessment of the extension of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings 103
Excisional cone as fertility-sparing treatment in early-stage cervical cancer. 102
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 100
Role of different approaches to the abdominal retroperitoneum for aortic lymphadenectomy in patients with gynecological cancers 99
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study 99
Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 99
Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): A feasibility study 97
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 96
Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome 95
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial 93
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments 93
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 92
Molecular profile of brca-negative long survivor high grade serous ovarian cancer patients using a somatic multigene panel 91
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 90
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 89
Targeting the hallmarks of ovarian cancer: The big picture 88
Perioperative outcomes of laparoendoscopic single-site surgery (LESS) versus conventional laparoscopy for adnexal disease: a case--control study 86
Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery Versus Standard Laparotomic Treatment: From Body to Mind and Back 86
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 86
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 86
Clinical impact of SARS-CoV-2 infection among patients with vulvar cancer: the Gemelli Vul.Can multidisciplinary team 86
Prognostic Significance of Ultrasound Characteristics and Body Mass Index in Patients with Apparent Early-Stage Cervical Cancer: A Single-Center, Retrospective, Cohort Study 85
TELELAP ALF-X Robotic-assisted Laparoscopic Hysterectomy: Feasibility and Perioperative Outcomes 85
Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature 85
Feasibility of tumor testing for BRCA status in high-grade serous ovarian cancer using fresh-frozen tissue based approach 85
Telelap ALF-X vs Standard Laparoscopy for the Treatment of Early-Stage Endometrial Cancer: A Single-Institution Retrospective Cohort Study 83
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status 83
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 82
The new robotic TELELAP ALF-X in gynecological surgery: single-center experience 82
BRCA testing delay during the COVID-19 pandemic: How to act? 82
Protective Role of Conization Before Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity-Score Matching Study 82
Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience 81
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 81
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 81
Resectability and Vascular Management of Retroperitoneal Gynecological Malignancies: A Large Single-institution Case-Series 81
Role of Intraoperative Ultrasound to Extend the Application of Minimally Invasive Surgery for Treatment of Recurrent Gynecologic Cancer 81
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer 80
Ultrasound and color power Doppler in the detection of metastatic omentum: a prospective study 80
Robotic treatment of colorectal endometriosis: technique, feasibility and short-term results 80
Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complications 80
Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications 80
Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience 80
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 79
Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients 79
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer 78
Robotic versus laparoscopic radical hysterectomy in early cervical cancer: A case matched control study 78
Systematic pelvic and aortic lymphadenectomy in advanced ovarian cancer patients at the time of interval debulking surgery: a double-institution case-control study 77
The role of liquid based cytology and ancillary techniques in the peritoneal washing analysis: Our institutional experience 77
Laparoscopic Management of a Small Bowel Recurrence of Endometrial Cancer 77
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases 77
Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis 77
Peritoneal Hpv-Dna Test In Cervical Cancer (Pioneer Study): A Proof Of Concept 77
Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer 77
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 77
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 76
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 76
Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: Proof of a concept 75
Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer. 75
Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience 75
Additional molecular and clinical evidence open the way to definitive IARC classification of the BRCA1 c.5332G > A (p.Asp1778Asn) variant 75
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850) 75
Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients 74
Radical hysterectomy after chemoradiation in FIGO stage III cervical cancer patients versus chemoradiation and brachytherapy: Complications and 3-years survival 74
Arterial-enteric fistula after pelvic lymphadenectomy in secondary cytoreductive surgery for recurrent ovarian cancer 74
Totale 11.611
Categoria #
all - tutte 126.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.696


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020153 0 0 0 0 0 0 0 0 0 0 0 153
2020/20211.872 129 161 227 142 232 66 198 50 192 115 296 64
2021/20222.597 172 118 31 257 103 67 97 433 123 154 448 594
2022/20235.671 752 719 454 770 384 733 275 401 693 98 245 147
2023/20243.305 118 887 104 287 104 373 226 125 74 193 353 461
2024/20256.209 157 134 529 236 518 297 292 304 1.039 948 1.500 255
Totale 24.390